DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer
Zhu Jian, Wang Yuyan, Duan Jianchun, Bai Hua, Wang Zhijie, Wei Lai, Zhao Jun, Zhuo Minglei, Wang Shuhang, Yang Lu, An Tongtong, Wu Meina, Wangjie